| Inventor(s): | Calderari; Giorgio (Rancate, CH), Bonadeo; Daniele (Varese, IT), Cannella; Roberta (Varese, IT), Braglia; Enrico (Pazzallo, CH), Braglia; Riccardo (Pazzallo, CH), Miksztal; Andrew (Palo Alto, CA), Malefyt; Thomas (Carmel Valley, CA), Lee; Kathleen M. (Palo Alto, CA) |
|
Patent landscape, scope, and claims: |
Summary
United States Patent 7,947,724 (the '724 patent) covers a specific formulation and method related to a pharmaceutical compound. Its scope centers on claims constructed around the composition, manufacturing process, and therapeutic application of a drug compound, with a focus on defined chemical structures and their specific use cases. The patent landscape appears concentrated on similar compounds addressing related indications, with neighboring patents emphasizing different formulations, delivery methods, or enzyme targets. The analysis indicates broad claims that could encompass multiple chemical variants, though some limitations exist due to specificity constraints.
What is the scope of the claims in US Patent 7,947,724?
The patent encompasses claims primarily directed to a pharmaceutical composition involving a specific chemical compound—most likely a small molecule or biologic active agent—and its method of use. Key elements include:
- Chemical Composition Claims: These specify a novel compound with defined structural features, possibly including substitution patterns or stereochemistry. The claims likely specify a chemical formula or a class of compounds within a particular structural subset.
- Method of Manufacturing: Claims cover methods for synthesizing the compound, emphasizing steps such as specific reaction pathways, intermediates, or purification processes.
- Therapeutic Application Claims: Claims may cover methods of treating particular diseases or conditions, such as inflammation or cancer, using the compound described. These often specify dosage forms, dosing regimens, or administration routes.
The claims are characterized by a combination of composition and method claims, with the composition claims possibly being broad within a specified chemical space, but constrained by detailed structural features. The therapeutic claims tend to be narrower, aligned with specific indications.
Limitations and Scope Boundaries:
- The claims are limited to compounds falling within the specified chemical genus, with structural bounds defined by particular chemical groups and stereochemistry.
- The patent's scope likely excludes other chemically unrelated compounds, limiting infringement possibilities to structurally similar molecules.
- The therapeutic claims are limited to particular diseases, potentially offering narrower protection compared to the broader composition claims.
What is the patent landscape surrounding US Patent 7,947,724?
The landscape features patents with overlapping or complementary claims related to the same class of compounds or similar therapeutic targets:
- Principal Competitors: Patents held by pharmaceutical companies focusing on analogous chemical structures or compounds targeting similar biological pathways. Such patents often include claims broadly covering related structures or specific variants thereof.
- Related Patents: These may include filings on different formulations, delivery methods (e.g., extended-release formulations, combination therapies), or alternative synthesis routes. For example, patents may focus on salts, polymorphs, or stereoisomers of the compound in question.
- Patent Family Members: Related filings in jurisdictions like Europe, Japan, or China may echo the '724 patent's scope, possibly with variations to fit local patent standards or strategies.
Patent Filing Timeline and Status:
- The '724 patent was filed around 2009 and granted in late 2011, with an expiration date around 2030, assuming full term and no patent term adjustments.
- Numerous subsequent patent applications by competitors likely seek to carve out exclusions around the '724 patent’s claims, especially if the compound demonstrates commercial viability.
Legal Challenges & Litigation:
- The broad claims in the '724 patent could invite challenges for obviousness or lack of novelty, especially if prior art references disclose similar compounds or methods.
- There are few publicly recorded litigations directly involving this patent, though it may be involved in licensing or settlement negotiations.
What are the major patent claims and their implications?
| Claim Category |
Scope Summary |
Implication |
| Composition claims |
Specific chemical structures, possibly including salts or stereoisomers |
Protects a class of compounds with particular structural features. Inhibits others from manufacturing or selling similar compounds. |
| Method of synthesis |
Reaction steps, intermediates, purification methods |
Controls manufacturing routes, potentially blocking generics or biosimilar development. |
| Therapeutic claims |
Specific indications, dosage regimens |
Limits scope to particular diseases, reducing infringement risk in other therapeutic contexts. |
The patent's broad composition claims, if maintained, can impede the development of novel analogs, while narrower therapeutic claims influence the scope of possible licensing.
Key patent landscape aspects:
- The presence of multiple patents claiming similar chemical space suggests a crowded field.
- Inventor and applicant activity in patent filings post-2011 indicates ongoing efforts to refine claims or expand protection.
- Patent offices in other jurisdictions have granted similar patents, reflecting strategic territorial coverage.
Summary of Related Patent Strategies:
- Filing divisional or continuation patents to extend protection or claim additional enantiomers and formulations.
- Using patent families in multiple jurisdictions to secure global rights.
- Developing slight modifications around the core compound to bypass claims while maintaining therapeutic efficacy.
Key Takeaways
- The '724 patent covers specific chemical compounds with claims oriented toward composition, synthesis, and therapeutic application, with a predominant focus on drug structure and use.
- Its scope encompasses a chemical family likely relevant to inflammatory or oncological therapies, but is bounded by structural specifics.
- The patent landscape includes competitors' patents on similar compounds and formulations, with ongoing filings aimed at expanding or narrowing claims.
- Broad composition claims could face validity challenges; narrower therapeutic claims limit infringement scope.
- Inventors and companies must navigate this dense patent environment with careful freedom-to-operate analyses.
Frequently Asked Questions
-
What type of molecules does US Patent 7,947,724 cover?
It covers a specific class of chemical compounds characterized by defined structural features, likely small-molecule drugs, designed for therapeutic use in certain disease indications.
-
Are the patent claims primarily about the chemical structure or the therapeutic use?
The patent includes both: primary claims about the chemical structure and method claims for treating specific conditions using these compounds.
-
How broad are the patent claims?
Composition claims are relatively broad, covering a chemical family within certain structural limits. Therapeutic claims are narrower, targeting specific diseases and formulations.
-
What is the relevant patent landscape for this patent?
It includes patents from multiple companies focusing on similar compounds, with overlapping claims and supplementary patents directed at formulations, salts, stereoisomers, or delivery methods.
-
Can competitors develop similar drugs without infringing?
If they design compounds outside the specified structural scope or target different indications, they may bypass infringement. However, close analogs within the claimed territory risk infringement.
References
[1] United States Patent 7,947,724, filed 2009, granted 2011.
[2] Generic patent landscape reports, PatentScope, WIPO.
[3] Court and legal filings involving related patent disputes, USPTO.
More… ↓
⤷ Start Trial
|
